IPASS: DATA FROM AN ONGOING STUDY OF THE TOLERABILITY AND EFFECTIVENESS OF INJECTABLE TESTOSTERONE UNDECANOATE FOR THE TREATMENT OF MALE HYPOGONADISM

被引：0

作者：

Zitzmann, M. ^{[1
]}

Hanisch, J. U. ^{[2
]}

Mattern, A. ^{[3
]}

机构：

[1] Univ Clin Munster, Ctr Reprod Med & Androl, Munster, Germany

[2] Bayer Vital GmbH, Leverkusen, Germany

[3] Bayer Schering Pharma AG, Berlin, Germany

来源：

JOURNAL OF SEXUAL MEDICINE | 2010年 / 7卷

关键词：

D O I：

暂无

中图分类号：

R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：97 / 97

页数：1

共 50 条

[31] Reduction of Mortality and Major Adverse Cardiovascular Events (MACE) in Men with Hypogonadism and Type 2 Diabetes (T2DM) Receiving Long-Term Treatment with Injectable Testosterone Undecanoate (TU): Ten-Year Data from a Urological Registry Study
Haider, Karim S.
Haider, Ahmad
Saad, Farid
DIABETES, 2019, 68
[32] Treatment with Testosterone Undecanoate Injections (TU) Results in Sustained Weight Loss in Men with Hypogonadism and Type 2 Diabetes: Update of Real-World Data from a Urological Practice
Haider, Ahmad
Haider, Karim S.
Saad, Farid
DIABETES, 2021, 70
[33] LONG-TERM TREATMENT WITH TESTOSTERONE UNDECANOATE (TU) IN HYPOGONADAL MEN WITH CARDIOVASCULAR DISEASES (CVD): OBSERVATIONAL DATA FROM A REGISTRY STUDY
Haider, Ahmad
Haider, Karim Sultan
Doros, Gheorghe
Traish, Abdulmaged
JOURNAL OF UROLOGY, 2015, 193 (04): : E771 - E771
[34] A THREE-YEAR SAFETY STUDY OF TREATMENT OF FEMALE-TO-MALE TRANSSEXUALS WITH LONG-ACTING PARENTERAL TESTOSTERONE UNDECANOATE
Gooren, L.
Jacobeit, J.
Schulte, H.
Saad, F.
JOURNAL OF SEXUAL MEDICINE, 2010, 7 : 53 - 53
[35] Type 2 diabetes and mortality in hypogonadal men improve upon long-term treatment with injectable Testosterone Undecanoate (TU): a controlled registry study
Saad, F.
Haider, A.
Haider, K. S.
Doros, G.
Traish, A.
DIABETOLOGIA, 2016, 59 : S184 - S184
[36] Hypogonadal Men with Inflammatory Bowel Diseases (M. Crohn and Colitis Ulcerosa) Benefit from Long-Term Treatment with Injectable Testosterone Undecanoate
Haider, Ahmad
Nasser, Mahmoud
Kurtz, Winfried
Doros, Gheorghe
Saad, Farid
JOURNAL OF MENS HEALTH, 2014, 11 (01) : A2 - A2
[37] Treatment with Testosterone Undecanoate Injections (TU) Improves Estimated Glomerular Filtration Rate (eGFR) in Men with Hypogonadism and Type 2 Diabetes Mellitus: Update of Real-World Data
Haider, Karim S.
Haider, Ahmad
Saad, Farid
DIABETES, 2021, 70
[38] PROSTATE SAFETY AND EFFECTIVENESS OF TESTOSTERONE REPLACEMENT THERAPY IN MALE HYPOGONADISM: FINAL RESULTS FROM THE LARGEST INTERNATIONAL TRIAL INVOLVING 1493 PATIENTS
Zitzmann, M.
Hanisch, J.
Mattern, A.
Maggi, M.
EUROPEAN UROLOGY SUPPLEMENTS, 2011, 10 (02) : 130 - 130
[39] Hypogonadal patients with Crohn's disease benefit from treatment with testosterone - data from an ongoing, long-term, observational registry study
Saad, F.
Nasser, M.
Doros, G.
Kurtz, W.
Haider, A.
Gooren, L.
JOURNAL OF CROHNS & COLITIS, 2014, 8 : S260 - S261
[40] Hypogonadal Patients with Crohn's Disease Benefit from Treatment with Testosterone Data from an Ongoing, Long-Term, Observational Registry Study
Saad, Farid
Nasser, Mahmoud
Doros, Gheorghe
Kurtz, Winfried
Haider, Ahmad
Gooren, Louis J.
ENDOCRINE REVIEWS, 2014, 35 (03)

← 1 2 3 4 5 →